Subclinical Fabry's disease occurring in the context of IgA nephropathy

Clinical Nephrology

Volumn 47, Issue 2, 1997, Pages 71-75

  Kawamura, O ^a   Sakuraba, H ^b   Itoh, K ^b   Suzuki, Y ^b   Doi, M ^a   Kuwabara, H ^a   Oshima, S ^a,d   Abe, S ^a   Warabi, H ^a   Yoshizawa, N ^c  

^a Self Defense Forces Central Hospital   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d Self Defense Forces Central Hospital   (Japan)

Author keywords

galactosidase; Fabry's disease; IgA nephropathy

Indexed keywords

ALPHA GALACTOSIDASE; GLYCOLIPID;

ADULT; ARTICLE; BIOACCUMULATION; CASE REPORT; DISEASE ASSOCIATION; ENZYME ACTIVITY; FABRY DISEASE; FIBROBLAST CULTURE; HEMIZYGOTE; HISTOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LEUKOCYTE; MALE;

ADULT; ALPHA-GALACTOSIDASE; ANTIGENS, CD; BIOPSY; FABRY DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; MALE; MICROSCOPY, ELECTRON; TRIHEXOSYLCERAMIDES;

EID: 0031054175     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Desnick RJ, Sweeley CC 1983 Fabry's disease: α-galactosidase A deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds). The Metabolic Basis of Inherited Disease. 5th edn. McGraw-Hill, NY, pp 906-944
2. Desnick RJ, Astrin KH, Bishop DF 1989 Fabry disease: molecular genetics of the inherited nephropathy. Adv Nephrol 18: 113-128
3. Gubler MC, Lenoir G, Grünfeld JP, Ulmann A, Droz D, Habib R 1978 Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 13: 223-235
4. Hamers MN, Donker-Koopman WE, Coulon-Morelec MJ, Dupouey P, Tager JM 1978 Characterization of antibodies against ceramidetrihexoside and globoside. Immunochem 15: 353-358
5. Kint JA 1970 Fabry's disease: α-galactosidase deficiency. Science 167: 1268-1269
6. Mayes JS, Scheerer JB, Sifers RN, Donaldson ML 1981 Differential assay for lysosomal α-galactosidases in human tissues and its application to Fabry's disease. Clin Chim Acta 112: 247-251
7. McNamara TE, Goodloe S, Butkus DE 1980 Myeloid bodies in patients without clinical Fabry's disease. Arch Pathol Lab Med 104: 14-16
8. Rosenmann E, Kobrin I, Cohen T 1983 Kidney involvement in systemic lupus erythematosus and Fabry's disease. Nephron 34: 180-184
9. Sakuraba H, Aoyagi T, Suzuki Y 1982 Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of β-galactosidase molecules. Clin Chim Acta 125: 275-282
10. Shibata S, Takeda T, Natori Y 1988 The structure of nephritogenoside: a nephritogenic glycopeptide with α-N-glycosidic linkage. J Biol Chem 263: 12483-12485